Source: Health Canada shortage reports · Updated Oct 27, 2026
Clomipramine has no current shortage reported in Canada. It has been in shortage before; the history is below.
A tricyclic antidepressant used to treat obsessive-compulsive disorder and depression.
Products affected
0 / 4
Reports on file
18
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Jun 19, 2026 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Oct 1, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Jun 22, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
25MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497506 · ended Jun 22, 2026 · Shortage of an active ingredient.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Apr 23, 2026 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
50MG · TABLET · APOTEX INC
DIN 00402591 · ended Mar 12, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Dec 22, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Oct 30, 2024 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
25MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497506 · ended Jan 31, 2024 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
50MG · TABLET · APOTEX INC
DIN 00402591 · ended Dec 21, 2023 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Jan 30, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Clomipramine. Health Canada has 18 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Clomipramine is classified under “ANTIDEPRESSANTS” (ATC N06AA).
Recent changes
Oct 27, 2026
Shortage resolved
Oct 2, 2026
Shortage resolved
Sep 18, 2026
Estimated end date pushed back : Sep 24, 2026 → Oct 2, 2026
Sep 4, 2026
Estimated end date pushed back : Sep 4, 2026 → Sep 24, 2026
Aug 21, 2026
New report filed
Jul 14, 2026
Shortage resolved
Jul 14, 2026
Shortage resolved
Common questions
What is Clomipramine used for?
A tricyclic antidepressant used to treat obsessive-compulsive disorder and depression.
When will Clomipramine be back in stock in Canada?
Clomipramine has no active shortage; supply is normal per Health Canada reports.
Why is Clomipramine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.